STAT1-mediated NK2R expression augments induction of anti-tumor effector T cells

被引:0
|
作者
Shen, Weidong [1 ]
Wang, Xiangdong [1 ]
Xiang, Huihui [1 ]
Shichi, Shunsuke [2 ]
Nakamoto, Hiroki [2 ]
Kimura, Saori [2 ]
Sugiyama, Ko [2 ]
Taketomi, Akinobu [2 ]
Kitamura, Hidemitsu [1 ]
机构
[1] Hokkaido Univ, Inst Med Genet, Div Funct Immunol, Sapporo, Japan
[2] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 1, Sapporo, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
E-1057
引用
收藏
页码:216 / 216
页数:1
相关论文
共 50 条
  • [41] Substance P modulation of anti-tumor immunity in a mouse model: characterization of NK and T cells
    Brand, Lucas
    Kastelic, Amanda
    Spampinato, Christine
    Manske, Jill
    FASEB JOURNAL, 2008, 22
  • [42] Foxp1 Regulates Anti-tumor Effector Functions of CD8+T cells in Ovarian Cancer
    Stephen, Tom
    Takata, Hiroshi
    Feng, Xiaoming
    Wang, Haikun
    Rutkowski, Melanie
    Allegrezza, Michael
    Hu, Hui
    Conejo-Garcia, Jose
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [43] PD-L1 blockade enhances anti-tumor efficacy of NK cells
    Oyer, Jeremiah L.
    Gitto, Sarah B.
    Altomare, Deborah A.
    Copik, Alicja J.
    ONCOIMMUNOLOGY, 2018, 7 (11):
  • [44] GILT in tumor cells improves T cell-mediated anti-tumor immune surveillance
    Li, Hongshuai
    Wang, Yuan
    Ma, Mengchu
    Hu, Lihong
    Zhang, Xinxin
    Xin, Lingbiao
    Zhang, Wei
    Sun, Xiaoming
    Ren, Yuanyuan
    Wang, Xinting
    Yang, Jie
    IMMUNOLOGY LETTERS, 2021, 234 : 1 - 12
  • [45] Committed memory effector type 2 cytotoxic T (Tc2) cells are ineffective in protective anti-tumor immunity
    Do, JS
    Choi, YH
    Shin, SH
    Yi, HK
    Hwang, PH
    Nam, SY
    IMMUNOLOGY LETTERS, 2004, 95 (01) : 77 - 84
  • [46] Bypassing STAT3-mediated Id2 inhibition improves the anti-tumor efficacy of dendritic cells
    Li, H.
    Liu, C.
    Xiao, Y.
    Chu, F.
    Liang, X.
    Peng, W.
    Neelapu, S.
    Sun, S. -C
    Hwu, P.
    Watowich, S.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 318 - 318
  • [47] Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cells
    Chaturvedi, Pallavi
    George, Varghese
    Shrestha, Niraj
    Wang, Meng
    Dee, Michael J.
    Zhu, Xiaoyun
    Liu, Bai
    Egan, Jack
    D'Eramo, Francesca
    Spanoudis, Catherine
    Gallo, Victor
    Echeverri, Christian
    You, Lijing
    Kong, Lin
    Fang, Byron
    Jeng, Emily K.
    Rhode, Peter R.
    Wong, Hing C.
    MOLECULAR THERAPY, 2022, 30 (03) : 1171 - 1187
  • [48] Activation of anti-tumor NK cells by gamma delta T lymphocytes through 4-1BB engagement
    Chapoval, Andrei
    Maniar, Amudhan
    Zhang, Xiaoyu
    Gastman, Brian R.
    Pauza, C. David
    Strome, Scott E.
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [49] Pgam1 Regulate Adaptive NK Cells in Anti-Viral and Anti-Tumor Response
    Xie, Juan
    Zhao, Ming
    Ding, Yiyang
    Shang, Qiannan
    Cao, Xunhong
    Zhao, Xiangyu
    BLOOD, 2023, 142
  • [50] iPSC-Derived NK Cells Synergize with T Cells and Anti-PD-1 Antibody to Mediate Durable Anti-Tumor Responses In Vivo
    Miller, Jeffrey S.
    Bjordahl, Ryan
    Gaidarova, Svetlana
    Mahmood, Sajid
    Rogers, Paul
    Moyar, Ge
    Blazar, Bruce R.
    Kaufman, Dan S.
    Valamehr, Bahram
    Cichocki, Frank
    BLOOD, 2019, 134